These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11336156)

  • 1. Intragastric nitric oxide/nitrite in Helicobacter pylori-infected subjects.
    Fändriks L; von Bothmer C; Aneman A; Olbe L; Pettersson A
    Scand J Gastroenterol; 2001 Apr; 36(4):347-50. PubMed ID: 11336156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation.
    Mowat C; Williams C; Gillen D; Hossack M; Gilmour D; Carswell A; Wirz A; Preston T; McColl KE
    Gastroenterology; 2000 Aug; 119(2):339-47. PubMed ID: 10930369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.
    Gillen D; Wirz AA; Neithercut WD; Ardill JE; McColl KE
    Gut; 1999 Apr; 44(4):468-75. PubMed ID: 10075952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection.
    Martínek J; Blum AL; Stolte M; Hartmann M; Verdú EF; Lühmann R; Dorta G; Wiesel P
    Aliment Pharmacol Ther; 1999 Jan; 13(1):27-34. PubMed ID: 9892876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragastric volatile N-nitrosamines, nitrite, pH, and Helicobacter pylori during long-term treatment with omeprazole.
    Vermeer IT; Engels LG; Pachen DM; Dallinga JW; Kleinjans JC; van Maanen JM
    Gastroenterology; 2001 Sep; 121(3):517-25. PubMed ID: 11522734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.
    Verdú EF; Armstrong D; Idström JP; Labenz J; Stolte M; Dorta G; Börsch G; Blum AL
    Gut; 1995 Dec; 37(6):743-8. PubMed ID: 8537042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole.
    Martínek J; Pantoflícková D; Hucl T; Benes M; Dorta G; Lukás M; Spicák J
    Eur J Gastroenterol Hepatol; 2004 May; 16(5):445-50. PubMed ID: 15097035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers.
    Verdú EF; Fraser R; Armstrong D; Blum AL
    Scand J Gastroenterol; 1994 Dec; 29(12):1065-9. PubMed ID: 7886393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the sensitivity to gastric acid inhibition Helicobacter pylori status-dependent?
    Smout AJ
    Scand J Gastroenterol Suppl; 1998; 225():32-5. PubMed ID: 9515750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of omeprazole dosing on the isolation of Helicobacter pylori from gastric aspirates.
    Williams MP; Sercombe JC; Lawson AJ; Slater E; Owen RJ; Pounder RE
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1161-9. PubMed ID: 10468697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.
    Chwiesko A; Charkiewicz R; Niklinski J; Luczaj W; Skrzydlewska E; Milewski R; Baniukiewicz A; Wroblewski E; Rosolowski M; Dabrowski A
    J Dig Dis; 2016 Sep; 17(9):588-599. PubMed ID: 27518195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors reduce the bioavailability of dietary vitamin C.
    Henry EB; Carswell A; Wirz A; Fyffe V; McColl KE
    Aliment Pharmacol Ther; 2005 Sep; 22(6):539-45. PubMed ID: 16167970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis.
    Verdú EF; Armstrong D; Idström JP; Labenz J; Stolte M; Börsch G; Blum AL
    Scand J Gastroenterol; 1996 Dec; 31(12):1151-6. PubMed ID: 8976005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid inhibitory potency of twice a day omeprazole is not affected by eradication of Helicobacter pylori in healthy volunteers.
    Thomson AB; Keelan M; Lastiwka R; Appelman-Eszcuck S; Zuk L; Drozdowski L; Prentice A; Sinclair P
    Helicobacter; 2003 Feb; 8(1):46-58. PubMed ID: 12603616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole.
    Verdú EF; Armstrong D; Fraser R; Viani F; Idström JP; Cederberg C; Blum AL
    Gut; 1995 Apr; 36(4):539-43. PubMed ID: 7737560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection.
    Bercík P; Verdú EF; Armstrong D; Idström JP; Cederberg C; Markert M; Crabtree JE; Stolte M; Blum AL
    Am J Gastroenterol; 2000 Apr; 95(4):947-55. PubMed ID: 10763943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment.
    Gillen D; Wirz AA; McColl KE
    Gastroenterology; 2004 Apr; 126(4):980-8. PubMed ID: 15057737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.
    Labenz J; Tillenburg B; Peitz U; Idström JP; Verdú EF; Stolte M; Börsch G; Blum AL
    Gastroenterology; 1996 Mar; 110(3):725-32. PubMed ID: 8608881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.
    Labenz J; Tillenburg B; Peitz U; Verdú E; Stolte M; Börsch G; Blum AL
    Gut; 1997 Jul; 41(1):33-6. PubMed ID: 9274468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.